About the Ulcerative Colitis Endoscopic Index of Severity (UCEIS)
The UCEIS grades the endoscopic severity of ulcerative colitis on a 0–8 scale by adding three explicitly defined descriptors scored at the single worst-affected segment seen at flexible sigmoidoscopy: vascular pattern (0–2), bleeding (0–3), and erosions and ulcers (0–3). A total of 0–1 is endoscopic remission or near-normal mucosa, 2–4 is mild-to-moderate activity, and 5–8 is severe. Its advantage over the older Mayo endoscopic subscore is reproducibility: each level of each descriptor carries a written definition, so the same appearance scores the same way between different endoscopists — the three descriptors together account for about 90% of the variance in an experienced endoscopist's overall severity judgement.
Formula
UCEIS = vascular pattern (0–2) + bleeding (0–3) + erosions and ulcers (0–3)- vascular pattern
- 0 normal arborisation, 1 patchy obliteration, 2 complete obliteration.
- bleeding
- 0 none, 1 mucosal, 2 luminal mild, 3 luminal moderate or severe.
- erosions and ulcers
- 0 none, 1 erosions, 2 superficial ulcer, 3 deep ulcer.
- Score the single worst-affected area within the segment examined, not an average across the colon.
- Each descriptor level has a precise written definition in the source paper — that is the point of the index, and where its reproducibility comes from.
- The range is 0–8. It is a simple unweighted sum; no descriptor is multiplied.
Interpreting the result
A UCEIS of 0–1 represents endoscopic remission or near-normal mucosa and, when it matches clinical remission, supports continuing maintenance therapy toward the treat-to-target goal of mucosal healing. Scores of 2–4 indicate mild-to-moderate endoscopic activity that persists as a driver of relapse even if symptoms have settled, so it argues for optimising rather than de-escalating therapy. A score of 5–8 is severe endoscopic activity; in an acute severe presentation a UCEIS at the top of the range (7–8) marks patients who will almost all need infliximab or ciclosporin beyond steroids. As an endoscopic measure it is interpreted together with the clinical picture — a low clinical index with a high UCEIS is exactly the symptom-inflammation mismatch that objective monitoring exists to catch.
| Score | Band | What it means | Action |
|---|---|---|---|
| 0–1 | Remission / minimal | Endoscopic remission or near-normal mucosa | Continue maintenance therapy; record as a baseline for future endoscopies |
| 2–4 | Mild to moderate | Mild-to-moderate endoscopic activity — an ongoing relapse driver | Optimise therapy toward endoscopic healing rather than symptom control alone |
| 5–8 | Severe | Severe endoscopic activity; UCEIS 7–8 in acute severe colitis predicts need for rescue therapy | Assess against Truelove and Witts criteria, exclude CDI and CMV, involve surgery early |
What the UCEIS needs (3 inputs)
- Vascular pattern
- Normal with clear arborisation (0), patchy obliteration (1), or complete obliteration (2).
- Bleeding
- None (0), mucosal — coagulated blood on the surface (1), luminal mild — some free liquid blood (2), or luminal moderate/severe — frank blood or oozing after washing (3).
- Erosions and ulcers
- None (0), erosions ≤ 5 mm (1), superficial ulcer > 5 mm (2), or deep excavated ulcer with a raised edge (3).
What it returns
- UCEIS total
- The sum of the three descriptors, from 0 to 8.
- Activity band
- Remission/minimal, mild-to-moderate, or severe.
How it is calculated
The index was derived from a library of 670 video sigmoidoscopies spanning the full range of disease, from which ten endoscopic descriptors were first defined and then narrowed to the three that carried almost all the information. A mixed regression model showed that vascular pattern, bleeding, and erosions and ulcers together explained about 90% of the variance in investigators' overall severity assessment on a 100-point visual analogue scale — the remaining seven candidate descriptors added little once these three were included. Each surviving descriptor was given explicit level definitions so that scoring depends on a written rule rather than a gestalt impression, which is what a subsequent reliability study set out to confirm.
Facts & figures
| Descriptor | Levels | Range |
|---|---|---|
| Vascular pattern | Normal / patchy / obliterated | 0–2 |
| Bleeding | None / mucosal / luminal mild / luminal moderate-severe | 0–3 |
| Erosions and ulcers | None / erosions / superficial ulcer / deep ulcer | 0–3 |
Total range 0–8, scored at the worst-affected area. The three descriptors together explained about 90% of the variance in overall endoscopic severity in the derivation study.
Evidence
Derivation — Travis (development)
2012 · n = 670A two-phase study using a library of 670 video sigmoidoscopies from patients with Mayo Clinic scores of 0–11, supplemented by videos of people without UC and of hospitalised acute severe cases. Investigators first agreed definitions for ten endoscopic descriptors, then rated overall severity on a 0–100 visual analogue scale, and a mixed regression model selected the descriptors that best predicted it.
The final three descriptors — vascular pattern, bleeding, and erosions and ulcers, each with precise definitions — explained about 90% of the variance in the overall assessment of endoscopic severity, with predictions ranging from 4 (normal) to 93 (worst) on the 100-point scale.
Reliability and initial validation — Travis
2013 · n = 57A new library of 57 flexible-sigmoidoscopy videos assessed by 25 investigators (each rating 28 videos, including duplicates to measure intra-observer reliability), blinded to clinical details except for selected duplicates used to test whether knowing symptoms changed scoring.
UCEIS scores correlated with overall severity at 0.93, Cronbach α was 0.86, and intra- and inter-observer reliability ratios were 0.96 and 0.88. Intra-observer κ for the total was 0.72 and inter-observer κ 0.50; the UCEIS accounted for a median of 86% of the variability in overall severity, and scoring was unaffected by knowledge of clinical details.
Prognosis in acute severe colitis — Corte
2015 · n = 8989 patients with acute severe ulcerative colitis (Truelove and Witts criteria), all given intravenous hydrocortisone, with the admission UCEIS related to rescue therapy, colectomy and readmission.
A higher UCEIS was associated with worse outcomes; when the admission UCEIS was 7 or 8, almost all patients needed infliximab or ciclosporin beyond steroids, marking a possible threshold for an early rescue-therapy decision.
How it compares
UCEIS vs Mayo endoscopic subscore
The UCEIS is the more reproducible endoscopic measure because every level is defined; the Mayo endoscopic subscore is simpler and more familiar but its single 0–3 judgement disagrees more often between endoscopists.
The Mayo endoscopic subscore packs the whole mucosal appearance into one 0–3 grade with no written anchors, which is quick but leaves the friable middle grades open to interpretation. The UCEIS breaks the appearance into three defined descriptors and sums them 0–8, raising inter-observer agreement. Studies comparing the two report that the UCEIS reflects clinical outcomes and long-term prognosis at least as well as, and by some measures better than, the Mayo endoscopic subscore — which is why the UCEIS is increasingly the endoscopic endpoint of choice in trials.
UCEIS vs Simple Clinical Colitis Activity Index (SCCAI)
The UCEIS measures mucosal inflammation at endoscopy; the SCCAI measures symptoms without endoscopy — they are complementary, and the mismatch between them is often the clinically useful finding.
The SCCAI is a symptom-only index scored in clinic or by the patient, while the UCEIS requires sigmoidoscopy and grades the mucosa directly. Symptoms and endoscopic activity diverge frequently in ulcerative colitis, so a patient can feel well with a UCEIS still showing active inflammation, or report symptoms with a healed mucosa. Modern treat-to-target management uses the SCCAI for frequent, cheap monitoring and the UCEIS to confirm the endoscopic healing that predicts durable remission.
Pearls & pitfalls
- Score only the worst-affected area within the segment examined. Averaging across the colon is a common error and is not how the index was derived.
- The value of the UCEIS is in its written level definitions — score against them rather than by overall impression, which is precisely the habit the index was built to replace.
- It is an endoscopic measure only. A UCEIS in remission with active symptoms, or active mucosa with settled symptoms, is a real and clinically important mismatch, not a scoring error.
- Bleeding is the least reproducible of the three descriptors (the lowest κ in the validation study); take particular care to distinguish mucosal from luminal blood and to wash before scoring.
- In acute severe colitis a UCEIS of 7–8 is prognostically meaningful — treat it as an early prompt toward rescue therapy rather than a number recorded for completeness.
Critical actions
- Record the UCEIS at every endoscopy so successive studies have a comparable, reproducible baseline rather than free-text impressions.
- Read the UCEIS alongside a clinical index (SCCAI or the clinical Mayo items); do not act on the endoscopic score in isolation.
- In an acute severe presentation, use a high UCEIS to prompt assessment against the Truelove and Witts criteria and early exclusion of Clostridioides difficile and cytomegalovirus.
- Aim for endoscopic healing (UCEIS 0–1) as the treatment target, not merely symptomatic improvement.
- Where UCEIS and symptoms disagree, investigate the discrepancy rather than averaging the two.
Why this score exists
The developers' explicit aim was reproducibility, not novelty of content. Endoscopists already recognised vascular pattern, bleeding and ulceration as the features that mattered; what was missing was agreement on how to score them, and the derivation study documented the problem directly — 76% agreement on a 'severe' appearance but only 27% on 'normal'. By writing a definition for every level of every descriptor and discarding the seven candidate features that added nothing once these three were in the model, the authors traded a richer but noisier picture for a lean index that different endoscopists would score the same way, which is the property a trial endpoint or a treat-to-target measure actually needs.
About the creator
First author, 2012 derivation and 2013 validation studies
Led the work that decomposed endoscopic severity into three explicitly defined descriptors, specifically to make scoring reproducible between endoscopists.
Senior author
Co-authored the derivation and validation, and has led much of the work on trial endpoints in inflammatory bowel disease.
Limitations
- It captures only the worst-affected area of the segment examined, so it does not describe disease extent or the distribution of inflammation along the colon.
- It is an endoscopic measure and carries no clinical, laboratory or histological information; histological activity can persist when the UCEIS reads remission.
- Bleeding, one of the three descriptors, has the lowest inter-observer agreement, so scores can still differ where blood is the dominant feature.
- The 0–8 total is not linearly tied to a specific management action across its whole range; the bands are a practical grouping, and the acute-severe prognostic threshold (7–8) comes from a specific inpatient population.
- It was derived and validated in adults; its performance as a paediatric endoscopic measure is less established.
If you are the patient
The UCEIS is a score doctors use during a camera test (sigmoidoscopy or colonoscopy) to measure how inflamed the lining of the bowel is in ulcerative colitis. They look at three things at the most affected spot — the blood-vessel pattern in the lining, whether there is any bleeding, and whether there are erosions or ulcers — and add them up to a number between 0 and 8. A score of 0 or 1 means the lining looks healed or almost normal, the middle range means some active inflammation, and a high score means severe inflammation. Because how you feel and how the lining looks do not always match, your team may use this score alongside your symptoms to decide whether treatment is working and whether it needs changing.
Frequently asked questions
What is the UCEIS and what does it score?#
The Ulcerative Colitis Endoscopic Index of Severity grades mucosal inflammation on a 0–8 scale from three descriptors seen at endoscopy: vascular pattern (0–2), bleeding (0–3), and erosions and ulcers (0–3), scored at the worst-affected area.
What UCEIS score means remission?#
A UCEIS of 0–1 is endoscopic remission or near-normal mucosa. Scores of 2–4 indicate mild-to-moderate activity and 5–8 indicate severe activity.
How is the UCEIS different from the Mayo endoscopic subscore?#
The Mayo endoscopic subscore is a single 0–3 judgement of the whole appearance; the UCEIS breaks it into three separately defined 0–2 and 0–3 descriptors summed to 0–8. Because each level has a written definition, the UCEIS is more reproducible between endoscopists.
Do you score the whole colon or one area?#
Only the single worst-affected area within the segment examined. The UCEIS was derived that way; averaging across the colon is not how the score is meant to be applied.
Does a high UCEIS predict needing surgery?#
In acute severe colitis it carries prognostic weight — a UCEIS of 7 or 8 on admission identifies patients who almost all go on to need rescue therapy with infliximab or ciclosporin beyond steroids, and it is associated with higher colectomy rates.
What are the three UCEIS descriptors?#
Vascular pattern, bleeding, and erosions and ulcers. Each is scored separately at the most severely affected area seen, and the three are summed. Crucially, all three are defined by published descriptors with agreed wording, which is what gives the UCEIS its reproducibility advantage over a single global impression.
What is the range of the UCEIS?#
Three to eleven when the descriptors are scored on their original scales, though the index is frequently reported on a 0 to 8 scale where each descriptor starts at zero. The two conventions describe the same assessment but produce different numbers, so a UCEIS quoted without saying which scale was used is ambiguous — record the convention alongside the score.
Is the UCEIS validated for measuring treatment response?#
Yes, and that is a meaningful advantage over the Mayo endoscopic subscore. The UCEIS was developed with formal attention to inter-observer variability and has been shown to be responsive to change, which makes it usable as a trial endpoint and for judging whether therapy has worked endoscopically. The Mayo endoscopic subscore is a single four-point global rating with poorer reproducibility, particularly at the boundary between scores of 0 and 1 that now defines endoscopic remission.
References
Original / primary reference
Validation and prognosis
- Travis SPL, Schnell D, Krzeski P, et al. Reliability and initial validation of the ulcerative colitis endoscopic index of severity. Gastroenterology. 2013;145(5):987-995.
- Corte C, Fernandopulle N, Catuneanu AM, et al. Association between the ulcerative colitis endoscopic index of severity (UCEIS) and outcomes in acute severe ulcerative colitis. J Crohns Colitis. 2015;9(5):376-381.
- Ikeya K, Hanai H, Sugimoto K, et al. The Ulcerative Colitis Endoscopic Index of Severity more accurately reflects clinical outcomes and long-term prognosis than the Mayo endoscopic score. J Crohns Colitis. 2016;10(3):286-295.